Page 3 - Next Test News Today

Eagle Health Investments LP reduced its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 54.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 204,861 shares of the company’s stock after selling 240,300 shares during the quarter. Guardant Health […]

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the sixteen research firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12-month […]

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Moderate Buy” from the sixteen research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 12-month price target […]

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 1-year […]

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 6,340,000 shares, a drop of 9.4% from the October 31st total of 7,000,000 shares. Based on an average trading volume of 1,800,000 shares, the days-to-cover ratio […]

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) insider Kumud Kalia sold 5,800 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $26.37, for a total value of $152,946.00. Following the completion of the transaction, the insider now directly owns 5,926 […]

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Guardant Health (NASDAQ:GH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional & Insider Ownership 1.1% of bioAffinity Technologies […]

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has received an average rating of “Buy” from the fifteen ratings firms that are presently covering the stock, Marketbeat.com reports. Fifteen investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have covered the stock in the last […]

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Buy” from the fifteen ratings firms that are presently covering the stock, Marketbeat.com reports. Fifteen analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on the stock in […]

Guardant Health (NASDAQ:GH – Get Free Report) was upgraded by investment analysts at Raymond James from a “market perform” rating to an “outperform” rating in a research note issued to investors on Monday, Marketbeat reports. The firm currently has a $27.00 price objective on the stock. Raymond James’ price target would suggest a potential upside […]